( TorontoVE:QPT )

News from quest pharmatech inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 09, 2010, 14:58 ET Quest PharmaTech Announces Formation of Clinical Advisory Panel

TSX Venture: QPT EDMONTON, July 9 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical...


May 11, 2010, 09:30 ET Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial

TSX Venture: QPT EDMONTON, May 11 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical...


Apr 06, 2010, 09:30 ET Oregovomab: Quest PharmaTech Discloses Cancer Immunotherapy Development Strategy

TSX Venture: QPT EDMONTON, April 6 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical...


Sep 30, 2009, 12:38 ET Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline

TSX Venture: QPT EDMONTON, Sept. 30 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical...


Mar 18, 2009, 07:00 ET Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052

TSX Venture: QPT EDMONTON, March 18 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical...


Mar 04, 2009, 12:36 ET Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors

TSX Venture: QPT EDMONTON, March 4 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company") a pharmaceutical...


Feb 02, 2009, 07:00 ET Quest PharmaTech Announces a Review of Strategic Alternatives to Enhance Shareholder Value

TSX Venture: QPT EDMONTON, Feb. 2 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical...


Jun 25, 2008, 01:00 ET Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal

EDMONTON, June 25 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company"), today announced interim results from...


Jun 02, 2008, 01:00 ET Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis

EDMONTON, June 2 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT), ("Quest" or the "Company"), today announced that its 12-patient,...


Apr 22, 2008, 01:00 ET Quest PharmaTech Receives Support from National Research Council's Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer

EDMONTON, April 22 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") is pleased to announce that it will receive generous...


Jan 28, 2008, 00:00 ET Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer

EDMONTON, Jan. 28 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") today announced that it has signed a collaborative...


Dec 17, 2007, 00:00 ET Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology

EDMONTON, Dec. 17 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX Venture Exchange: QPT) today announced that it has signed an agreement with...


May 14, 2007, 01:00 ET Quest PharmaTech and Paramount BioSciences Sign Exclusive Multinational License Agreement to Develop and Commercialize SonoLight Technology for Dermatology Applications

EDMONTON, AB and SAN DIEGO, CA, May 14 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest") (TSX: QPT) announced today that Paramount...


May 02, 2007, 01:00 ET Quest PharmaTech's Prostate Cancer Program Update

EDMONTON, May 2 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") Quest is pleased to provide an update on the...


Jan 09, 2007, 00:00 ET Quest PharmaTech Initiates a Fifty Patient Pivotal Clinical Trial for Cosmetic Hair Removal Applications

EDMONTON, Jan. 9 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or the "Company") is pleased to announce that it has received clearance...


Jun 20, 2006, 01:00 ET Quest Pharmatech INC. announces positive Phase I clinical trial results for cosmetic hair removal application

EDMONTON, June 20 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. ("Quest" or "the Company") is pleased to announce that the Phase I clinical...